BDH Industries Ltd Stock Analysis

BSE: 524828 | NSE: MBIND | Pharmaceuticals & Drugs | Small Cap

BSE Share Price Jan 17, 18:01
154.85 -1.95 (-1.24%)

DeciZen - Make an Informed Decision on BDH Inds

M-Cap below 100cr DeciZen not available

10 Year X-Ray:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide
ROCE % 6.2%8%8.8%8.6%9.9%9.6%10.3%12.1%13.6%13.2%-
Value Creation Index -0.6-0.4-0.4-0.4-0.3-0.3-0.3-0.1-0.0-0.1-

Growth Parameters

Growth Parameters Colour Code Guide
Sales 40.240.542.644.646.143.74151.759.557.563
YoY Gr. Rt. %-1%5.2%4.6%3.4%-5.3%-6.1%26%15.1%-3.4%-
Adj EPS 1.92.944.
YoY Gr. Rt. %-55.3%37%11.5%25.1%3.9%12.8%28.3%23%7.1%-
BVPS (₹) 33.435.137.33944.64851.656.963.772.275
Adj Net Profit
Cash Flow from Ops. 8.653.
Debt/CF from Ops.


CAGR Colour Code Guide
9 Years 5 Years 3 Years 1 Years
Sales 4.1%4.5%11.9%-3.4%
Adj EPS 21.8%14.6%19.1%7.1%
BVPS 910.111.913.2
Share Price 25.2% 16.4% 31.9% 84.2%

Key Financial Parameters

Performance Ratio Colour Code Guide
Return on Equity % 5.37.910.210.912.511.812.514.716.415.615.1
Op. Profit Mgn %
Net Profit Mgn %
Debt to Equity
Working Cap Days 132122127132126111132155146156266
Cash Conv. Cycle 7033130-18-34-44-13-4-6133

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 11.89%

Net Profit is growing at healthy rate in last 3 years 19.10%

Sales growth is good in last 4 quarters at 23.95%

Return on Equity has declined versus last 3 years average to 15.10%

Latest Financials - BDH Industries Ltd.

Standalone Consolidated
TTM EPS (₹) 11.1 -
TTM Sales (₹ Cr.) 63 -
BVPS (₹.) 75 -
Reserves (₹ Cr.) 37 -
P/BV 2.07 -
PE 13.93 -
From the Market
52 Week Low / High (₹) 80.20 / 180.00
All Time Low / High (₹) 2.45 / 180.00
Market Cap (₹ Cr.) 89.2
Equity (₹ Cr.) 5.8
Face Value (₹) 10
Industry PE 40.9

Management X-Ray:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *
* Pledged shares as % of Promoter's holding (%)

Event Update

Analyst's Notes


About BDH Industries Ltd

BDH Industries was incorporated on December 5, 1990 and was converted into a public limited company on April 29, 1994.

BDH Industries is engaged in the manufacture and marketing of formulations and bulk drugs. It is today recognised as one of India's leading manufacturers of therapeutic formulations covering wide range of pharmaceuticals.

BDH exports a wide range of finished pharmaceutical formulations and bulk drugs to leading organizations in several countries, including Australia, Bolivia, Denmark, Dominican Republic, Germany, Ghana, Japan, Kenya, Madagascar, Malaysia, Mozambique, Netherlands, Niger, Nigeria, Papua New Guinea, Yemen, Singapore, Sri Lanka, Sudan, West Indies, Zambia, Zimbabwe, etc.

Products offered by the Company:

Some of its therapeutical categories are:

1. Anti-cancer 2. Antibiotics & Anti-microbials 3. Cardiovascular 4. Psychotropic 5. External Preparations 6. Sterile Opthalmics Preparations 7. Generics & Branded Generics 8. Injectables

It also manufactures sildenafil citrate tablets for male impotency


  • The Government of the India has accorded 'Star Export House' status to the company
  • The Government of India also accredited the company with WHO-GMP Certification since 1982.
  • It has received Federation of Indian Export Organisations (FIEO) Export Award 'Niryat Shree'
  • The company has received Chemexcil Top Export Award
  • It has also received Chemexcil Trishul Award for Consistent Export Performance
  • It has received the Government of Maharashtra's Export Award
  • Ministry of Commerce's Award from the President of India was conferred on the company.
  • 2010
    • BDH Industries won ‘Good Corporate Citizen’ Award by Bombay Chamber of Commerce & Industry 2010
    • BDH Industries won State Pharmaceutical Corporation (SPC) Sri Lanka Merit Award 2010
    • WHO-GMP Certificatation since 1982, renewed WHO-GMP in 2010
Read More Read Less